Viewing data from:

TRIAZOLAM

ANDA

TRIAZOLAM | A213003 | ZYDUS PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: HALCION(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.3501

per ea

Lowest NADAC/Unit

$0.3397

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70710128901TRIAZOLAM 0.25 MG TABLET	$0.3501	EA	Generic	—	2026-06-17
70710128905TRIAZOLAM 0.25 MG TABLET	$0.3501	EA	Generic	—	2026-06-17
70710152101TRIAZOLAM 0.125 MG TABLET	$0.3397	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs5 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CAMBREX PROFARMACO MILANO SRLTRIAZOLAM

DMF 87041990

CENTAUR PHARMACEUTICALS PRIVATE LTDTRIAZOLAM USP

DMF 359222021

DIOSYNTH BVInactiveTRIAZOLAM

DMF 86241990

ZAMBON SPAInactiveTRIAZOLAM

DMF 88591990

ORION CORP LTDInactiveTRIAZOLAM

DMF 92001991

FINE CHEMICALS CORPInactiveTRIAZOLAM

DMF 93421991

PHARMACIA AND UPJOHN SUB PFIZER INCInactiveTRIAZOLAM USP MICRONIZED

DMF 243142010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 0.125MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 28, 2022

No patent or exclusivity listings for this strength.

#002 — 0.25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 28, 2022